Canada markets closed

Vistagen Therapeutics, Inc. (VTGN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.7400-0.0900 (-1.86%)
At close: 04:00PM EDT
4.7000 -0.04 (-0.84%)
After hours: 06:10PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
Total Revenue
1,042
-227.3
1,109
1,090
Operating Expenses
Research Development
21,923
44,377
35,408
11,926
Selling General and Administrative
13,021
14,664
13,248
7,098
Total Operating Expenses
34,944
59,041
48,656
19,024
Operating Income or Loss
-33,901
-59,268
-47,547
-17,934
Interest Expense
-
23
0
13
Total Other Income/Expenses Net
-
-
-232
0.6
Income Before Tax
-32,065
-59,242
-47,759
-17,932
Income Tax Expense
2.9
5.9
3.4
2.6
Income from Continuing Operations
-32,068
-59,248
-47,762
-17,934
Net Income
-32,068
-59,248
-47,762
-17,934
Net Income available to common shareholders
-32,068
-59,248
-48,707
-42,320
Basic EPS
-4.65
-8.51
-7.38
-14.70
Diluted EPS
-4.65
-8.51
-7.38
-14.70
Basic Average Shares
7,873
6,959
6,600
2,871
Diluted Average Shares
7,873
6,959
6,600
2,871